These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 9003520)
1. Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro. Zhao R; al-Said NH; Sternbach DL; Lown JW J Med Chem; 1997 Jan; 40(2):216-25. PubMed ID: 9003520 [TBL] [Abstract][Full Text] [Related]
2. Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity. Sukhanova A; Grokhovsky S; Zhuze A; Devy J; Pluot M; Oleinikov V; Nabiev I Anticancer Res; 2003; 23(3B):2609-15. PubMed ID: 12894548 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids. Fox BM; Xiao X; Antony S; Kohlhagen G; Pommier Y; Staker BL; Stewart L; Cushman M J Med Chem; 2003 Jul; 46(15):3275-82. PubMed ID: 12852757 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors. Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives. Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996 [TBL] [Abstract][Full Text] [Related]
6. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts. Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, topoisomerase I inhibitory activity and in vitro cytotoxicity of camptothecin derivatives bearing five-membered heterocycle containing 10-substituents. Zhao R; Guan LL; Oreski B; Lown JW Anticancer Drug Des; 1998 Mar; 13(2):145-57. PubMed ID: 9524556 [TBL] [Abstract][Full Text] [Related]
9. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and topoisomerase II inhibition activity of 4'-demethylepipodophyllotoxin-lexitropsin conjugates. Gupta R; al-Said NH; Oreski B; Lown JW Anticancer Drug Des; 1996 Jun; 11(4):325-38. PubMed ID: 8679055 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. Bowman KJ; Newell DR; Calvert AH; Curtin NJ Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of 7-ethyl-9-alkyl derivatives of camptothecin. Gao H; Zhang X; Chen Y; Shen H; Sun J; Huang M; Ding J; Li C; Lu W Bioorg Med Chem Lett; 2005 Apr; 15(8):2003-6. PubMed ID: 15808456 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activity of substituted 7-aryliminomethyl derivatives of camptothecin. Dallavalle S; Merlini L; Morini G; Musso L; Penco S; Beretta GL; Tinelli S; Zunino F Eur J Med Chem; 2004 Jun; 39(6):507-13. PubMed ID: 15183909 [TBL] [Abstract][Full Text] [Related]
14. [Synthesis of camptothecin glycosides by phase transfer-catalysis and its inhibitory activity against topo I]. Li QY; Zhang Y; Yao LP; Fu YJ; Zu YG; Chen XQ; Zheng CY Yao Xue Xue Bao; 2005 Dec; 40(12):1116-21. PubMed ID: 16496676 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues. Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of new 9-substituted camptothecins. Dallavalle S; Rocchetta DG; Musso L; Merlini L; Morini G; Penco S; Tinelli S; Beretta GL; Zunino F Bioorg Med Chem Lett; 2008 May; 18(9):2781-7. PubMed ID: 18434153 [TBL] [Abstract][Full Text] [Related]
17. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs. Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837 [TBL] [Abstract][Full Text] [Related]
18. Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin. Lackey K; Sternbach DD; Croom DK; Emerson DL; Evans MG; Leitner PL; Luzzio MJ; McIntyre G; Vuong A; Yates J; Besterman JM J Med Chem; 1996 Feb; 39(3):713-9. PubMed ID: 8576914 [TBL] [Abstract][Full Text] [Related]
19. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance. Wang LF; Ting CY; Lo CK; Su JS; Mickley LA; Fojo AT; Whang-Peng J; Hwang J Cancer Res; 1997 Apr; 57(8):1516-22. PubMed ID: 9108454 [TBL] [Abstract][Full Text] [Related]
20. Human DNA topoisomerase inhibitors from Potentilla argentea and their cytotoxic effect against MCF-7. Tomczyk M; Drozdowska D; Bielawska A; Bielawski K; Gudej J Pharmazie; 2008 May; 63(5):389-93. PubMed ID: 18557426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]